W93
The W93 is a thermonuclear warhead under development for the United States Navy's submarine-launched ballistic missiles, designated as the 93rd nuclear weapon design considered in U.S. history.[1]Initiated in 2021 through the joint Department of Defense-Department of Energy Nuclear Weapons Lifecycle Process, the W93/Mk7 program aims to provide a modernized warhead paired with the Mk7 reentry body for Trident II (D5LE and D5LE2) missiles deployed on Ohio-class and Columbia-class submarines.[2][3]
It seeks to reduce over-reliance on the W76 warhead, which constitutes the majority of the sea-based leg of the U.S. nuclear triad, while complementing the higher-yield W88 by offering enhanced flexibility, safety, security, and adaptability to evolving threats without increasing the size of the deployed stockpile or requiring underground nuclear explosive testing.[3][4][2]
As of May 2025, the program has advanced to Phase 2A (design definition and options analysis) following completion of Phase 1 concept assessment and initiation of Phase 2 feasibility studies, with production targeted for the late 2030s to address warhead age-out risks in the 2040s and support U.S. Strategic Command requirements during the transition to the Columbia-class fleet.[2][3]
The design leverages previously tested nuclear components to facilitate easier manufacturing and maintenance, reinforcing the U.S. nuclear deterrent's credibility and industrial base while fulfilling obligations under the U.S.-UK Mutual Defense Agreement to aid allied modernization efforts.[3][2][4]
Although proponents emphasize its role in sustaining deterrence amid adversary advancements, the program's projected multi-billion-dollar costs over decades have drawn scrutiny from critics who contend it duplicates existing capabilities and may prioritize foreign partnerships over domestic necessities.[5][6]